Case number 2:17-cv-00558
Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 82 | Motion to Amend/Correct (3) |
| Jul 8, 2020 | 75 | Motion for Leave to File (3) |
| Jul 8, 2020 | 71 | Motion to Amend/Correct (4) |
| Jul 8, 2020 | 70 | Motion to Amend/Correct (4) |
| Jul 8, 2020 | 60 | Motion for Leave to File (3) |
| Jul 8, 2020 | 58 | Motion for Leave to File (3) |
| Jul 8, 2020 | 56 | Motion for Extension of Time to File (3) |
| Jul 8, 2020 | 49 | Motion for Miscellaneous Relief (3) |
| Jul 8, 2020 | 39 | Motion for Protective Order (3) |
| Jul 8, 2020 | 36 | Motion for Miscellaneous Relief (5) |
| Jul 8, 2020 | 35 | Motion for Miscellaneous Relief (3) |
| Jul 8, 2020 | 26 | Motion for Leave to File (3) |
| Jul 8, 2020 | 21 | Motion for Leave to File (2) |
| Jul 8, 2020 | 18 | Motion for Leave to File (3) |
| Jul 8, 2020 | 13 | Motion for Extension of Time to File Response/Reply (3) |
| Jul 8, 2020 | 12 | Motion for Extension of Time to File Response/Reply (3) |
| Jul 8, 2020 | 9 | Motion to Dismiss (29) |
| Jun 22, 2018 | N/A | Case Transferred Out - District Transfer (0) Docket Text: Interdistrict transfer to the District of New Jersey [LIVE]. (nkl, ) |
| Jun 22, 2018 | N/A | Acknowledgment of Receipt (0) Docket Text: DETAILS: Case transferred from Texas Eastern has been opened in District of New Jersey [LIVE] as case 3:18-cv-10952, filed 06/22/2018. (nkl, ) |
| Jun 12, 2018 | 83 | Order Staying Case (1) Docket Text: ORDER STAYING CASE. Signed by District Judge Rodney Gilstrap on 6/11/2018. (nkl, ) |
| Jun 7, 2018 | 82 | Text of Proposed Order - Exhibit A - Proposed Amended Docket Control Order (6) |
| Jun 7, 2018 | 82 | Main Document (3) Docket Text: Unopposed MOTION to Amend/Correct [37] Order,,, Terminate Motions,,, Set Deadlines/Hearings,,, Scheduling Order,, - Unopposed Motion to Amend Docket Control Order (Re: Dkt. 37) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order - Exhibit A - Proposed Amended Docket Control Order)(Davis, William) |
| May 30, 2018 | 80 | Order on Motion to Dismiss (14) Docket Text: ORDER granting in part and denying in part [9] Motion to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406. Signed by District Judge Rodney Gilstrap on 5/29/2018. (nkl, ) |
| May 30, 2018 | 81 | Redacted Document (30) Docket Text: REDACTION to [78] Sealed Document Amended Answer, Defenses, and Counterclaims of Lupin Atlantis Holdings SA by Lupin Atlantis Holdings SA. (Mathas, Kurt) |
| May 29, 2018 | 79 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [75] Motion for Leave to File Under Seal its Amended Answer, Defenses, and Counterclaims. Signed by District Judge Rodney Gilstrap on 5/29/2018. (nkl, ) |
| May 25, 2018 | N/A | Notice of Deficiency (0) Docket Text: NOTICE of Deficiency regarding the 76 submitted NO CERTIFICATE OF AUTHORIZATION TO FILE UNDER SEAL. Correction should be made by one business day (ch, ) |
| May 24, 2018 | 75 | Text of Proposed Order (1) |
| May 24, 2018 | 77 | Claim Construction Chart or Claim Construction and Prehearing Statement (5) |
| May 24, 2018 | 77 | Exhibit A - Joint Claim Construction Chart (6) |
| May 24, 2018 | 75 | Main Document (3) Docket Text: Unopposed MOTION for Leave to File Under Seal its Amended Answer, Defenses, and Counterclaims by Lupin Atlantis Holdings SA. (Attachments: # (1) Text of Proposed Order)(Mathas, Kurt) |
| May 24, 2018 | 77 | Main Document (5) Docket Text: Joint Claim Construction and Prehearing Statement by Endo Pharmaceuticals Inc. (Attachments: # (1) Exhibit A - Joint Claim Construction Chart) (Davis, William) |
| May 22, 2018 | 73 | Notice of Attorney Appearance (3) Docket Text: NOTICE of Attorney Appearance by Sarah Wenxuan Wang on behalf of Endo Pharmaceuticals Inc. (Wang, Sarah) |
| May 22, 2018 | 74 | Notice of Attorney Appearance (3) Docket Text: NOTICE of Attorney Appearance by Jennifer Koh on behalf of Endo Pharmaceuticals Inc. (Koh, Jennifer) |
| May 18, 2018 | 71 | Text of Proposed Order (5) |
| May 18, 2018 | 72 | Notice (Other) (2) |
| May 18, 2018 | 72 | Exhibit A (21) |
| May 18, 2018 | 71 | Main Document (4) Docket Text: Joint MOTION to Amend/Correct [37] Order,,, Terminate Motions,,, Set Deadlines/Hearings,,, Scheduling Order,, Docket Control Order and Defer Indefiniteness Terms Until Trial by Lupin Atlantis Holdings SA. (Attachments: # (1) Text of Proposed Order)(Johnson, Michael) |
| May 18, 2018 | 72 | Main Document (2) Docket Text: NOTICE by Lupin Atlantis Holdings SA re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406Notice of Supplemental Authority (Attachments: # (1) Exhibit A)(Johnson, Michael) |
| May 17, 2018 | N/A | Notice of Deficiency (0) |
| May 17, 2018 | 70 | Text of Proposed Order (5) |
| May 17, 2018 | 70 | Main Document (4) Docket Text:DEFICIENT DOCUMENT Joint MOTION to Amend/Correct [37] Order,,, Terminate Motions,,, Set Deadlines/Hearings,,, Scheduling Order,, Docket Control Order and Defer Indefiniteness Terms Until Trial by Lupin Atlantis Holdings SA. (Attachments: # (1) Text of Proposed Order)(Johnson, Michael) Modified on 5/17/2018 (nkl, ). |
| May 7, 2018 | 69 | Notice (Other) (2) Docket Text: NOTICE by Lupin Atlantis Holdings SA re [37] Order,,, Terminate Motions,,, Set Deadlines/Hearings,,, Scheduling Order,, Notice of Compliance With P.R. 4-2 (Johnson, Michael) |
| May 5, 2018 | 68 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [60] MOTION for Leave to File DEFENDANTS UNOPPOSED MOTION FOR LEAVE TO FILE UNDER SEAL ITS SUPPLEMENTAL BRIEF REGARDING TRANSFER UNDER 28 U.S.C. § 1404. Signed by District Judge Rodney Gilstrap on 5/5/2018. (ch, ) |
| May 4, 2018 | 67 | Notice (Other) (2) Docket Text: NOTICE by Endo Pharmaceuticals Inc. of Compliance with P.R. 4-2 (Re: Dkt. 37) (Davis, William) |
| May 3, 2018 | 65 | Order on Motion for Leave to File (1) Docket Text: ORDER granting [58] Motion for Leave to File Plaintiff's Supplemental Brief Regarding Transfer Under 28 U.S.C. § 1404 UNDER SEAL (Re: Dkts. 9, 53 and 57). Signed by District Judge Rodney Gilstrap on 5/2/2018. (nkl, ) |
| May 3, 2018 | 66 | Redacted Document (16) |
| May 3, 2018 | 66 | Exhibit 1 PUBLIC (4) |
| May 3, 2018 | 66 | Exhibit A PUBLIC (9) |
| May 3, 2018 | 66 | Exhibit B PUBLIC (11) |
| May 3, 2018 | 66 | Exhibit C REDACTED (1) |
| May 3, 2018 | 66 | Exhibit D PUBLIC (3) |
| May 3, 2018 | 66 | Exhibit E PUBLIC (3) |
| May 3, 2018 | 66 | Exhibit F PUBLIC (3) |
| May 3, 2018 | 66 | Exhibit G PUBLIC (4) |
| May 3, 2018 | 66 | Exhibit H PUBLIC (3) |
| May 3, 2018 | 66 | Exhibit I PUBLIC (3) |
| May 3, 2018 | 66 | Exhibit J PUBLIC (9) |
| May 3, 2018 | 66 | Exhibit K PUBLIC (10) |
| May 3, 2018 | 66 | Exhibit L REDACTED (1) |
| May 3, 2018 | 66 | Exhibit M PUBLIC (5) |
| May 3, 2018 | 66 | Exhibit 2 PUBLIC (3) |
| May 3, 2018 | 66 | Main Document (16) Docket Text: REDACTION to [62] Sealed Document, Defendant's Supplemental Memorandum in Support of its Motion to Transfer Venue under 28 U.S.C. § 1404 by Lupin Atlantis Holdings SA. (Attachments: # (1) Exhibit 1 PUBLIC, # (2) Exhibit A PUBLIC, # (3) Exhibit B PUBLIC, # (4) Exhibit C REDACTED, # (5) Exhibit D PUBLIC, # (6) Exhibit E PUBLIC, # (7) Exhibit F PUBLIC, # (8) Exhibit G PUBLIC, # (9) Exhibit H PUBLIC, # (10) Exhibit I PUBLIC, # (11) Exhibit J PUBLIC, # (12) Exhibit K PUBLIC, # (13) Exhibit L REDACTED, # (14) Exhibit M PUBLIC, # (15) Exhibit 2 PUBLIC)(Johnson, Michael) |
| Apr 30, 2018 | 64 | Redacted Document (21) |
| Apr 30, 2018 | 64 | Exhibit - Declaration of Sarah Wang in Support of Plaintiff's Supplemental (3) |
| Apr 30, 2018 | 64 | Exhibit 1 - Excerpts from Endo_Nascobal_00051023 (REDACTED IN FULL) (1) |
| Apr 30, 2018 | 64 | Exhibit 2 - PPD (PUBLIC) (5) |
| Apr 30, 2018 | 64 | Exhibit 3 - Par Facilities (PUBLIC) (3) |
| Apr 30, 2018 | 64 | Exhibit 4 - Excerpts from Lupin's Invalidity Contentions (REDACTED IN FULL) (1) |
| Apr 30, 2018 | 64 | Exhibit 5 - Excerpts from Federal Judiciary (PUBLIC) (3) |
| Apr 30, 2018 | 64 | Exhibit 6 - Lupin's Waiver Request (REDACTED IN FULL) (1) |
| Apr 30, 2018 | 64 | Exhibit - Declaration of Carol L. Purcell In Support of Plaintiff's Supplem (2) |
| Apr 30, 2018 | 64 | Main Document (21) Docket Text: REDACTION to [59] Sealed Patent Document,,, by Endo Pharmaceuticals Inc.. (Attachments: # (1) Exhibit - Declaration of Sarah Wang in Support of Plaintiff's Supplemental Brief Regarding Transfer Under 28 U.S.C § 1404 (REDACTED), # (2) Exhibit 1 - Excerpts from Endo_Nascobal_00051023 (REDACTED IN FULL), # (3) Exhibit 2 - PPD (PUBLIC), # (4) Exhibit 3 - Par Facilities (PUBLIC), # (5) Exhibit 4 - Excerpts from Lupin's Invalidity Contentions (REDACTED IN FULL), # (6) Exhibit 5 - Excerpts from Federal Judiciary (PUBLIC), # (7) Exhibit 6 - Lupin's Waiver Request (REDACTED IN FULL), # (8) Exhibit - Declaration of Carol L. Purcell In Support of Plaintiff's Supplemental Brief Regarding Transfer Under 28 U.S.C § 1404 (REDACTED))(Davis, William) |
| Apr 27, 2018 | N/A | Notice of Docket Correction (0) Docket Text:***FILED IN ERROR - was filed using the wrong docket event. Document # 61, SEALED MOTION DEFENDANTS SUPPLEMENTAL MEMORANDUM IN SUPPORT OF ITS MOTION TO TRANSFER VENUE UNDER 28 U.S.C. § 1404. PLEASE IGNORE.*** (nkl, ) |
| Apr 26, 2018 | 58 | Text of Proposed Order (1) |
| Apr 26, 2018 | 60 | Text of Proposed Order (1) |
| Apr 26, 2018 | 58 | Main Document (3) Docket Text: Unopposed MOTION for Leave to File Plaintiff's Supplemental Brief Regarding Transfer Under 28 U.S.C. § 1404 UNDER SEAL (Re: Dkts. 9, 53 and 57) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Apr 26, 2018 | 60 | Main Document (3) Docket Text: Unopposed MOTION for Leave to File DEFENDANTS UNOPPOSED MOTION FOR LEAVE TO FILE UNDER SEAL ITS SUPPLEMENTAL BRIEF REGARDING TRANSFER UNDER 28 U.S.C. § 1404 by Lupin Atlantis Holdings SA. (Attachments: # (1) Text of Proposed Order)(Johnson, Michael) |
| Apr 19, 2018 | 57 | Order on Motion for Extension of Time to File (1) Docket Text: ORDER granting [56] Motion for Extension of Time to File Parties' Supplemental Briefing. Signed by District Judge Rodney Gilstrap on 4/19/2018. (ch, ) |
| Apr 18, 2018 | 56 | Text of Proposed Order (1) |
| Apr 18, 2018 | 56 | Main Document (3) Docket Text: Joint MOTION for Extension of Time to File Parties' Supplemental Briefing (Re: Dkt. 53) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Apr 16, 2018 | 55 | Notice (Other) (2) Docket Text: NOTICE by Lupin Atlantis Holdings SA LUPIN ATLANTIS HOLDINGS SA'S NOTICE OF COMPLIANCE WITH P.R. 3-8(C) AND 3-8(D) (Johnson, Michael) |
| Apr 13, 2018 | 54 | Notice (Other) (2) Docket Text: NOTICE by Endo Pharmaceuticals Inc. of Compliance with P.R. 4-1 (Re: Dkt. 37) (Davis, William) |
| Apr 10, 2018 | 52 | Order (8) Docket Text: DISCOVERY ORDER re [36] Opposed MOTION for Entry of Discovery Order (Re: Dkt. 25) filed by Endo Pharmaceuticals Inc.. Signed by District Judge Rodney Gilstrap on 4/9/2018. (nkl, ) |
| Apr 10, 2018 | 53 | Order (1) Docket Text: ORDER re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 filed by Lupin Atlantis Holdings SA. Signed by District Judge Rodney Gilstrap on 4/9/2018. (nkl, ) |
| Mar 26, 2018 | 51 | Notice (Other) (2) Docket Text: NOTICE by Endo Pharmaceuticals Inc. of Compliance with P.R. 3-8(e) (Re: Dkt. 37) (Davis, William) |
| Feb 22, 2018 | 50 | Order (8) Docket Text: ORDER REGARDING E-DISCOVERY re [49] Joint MOTION for Entry of Agreed E-Discovery Order filed by Endo Pharmaceuticals Inc.. Signed by District Judge Rodney Gilstrap on 2/22/2018. (nkl, ) |
| Feb 20, 2018 | 49 | Exhibit A - Proposed E-Discovery Order (9) |
| Feb 20, 2018 | 49 | Main Document (3) Docket Text: Joint MOTION for Entry of Agreed E-Discovery Order by Endo Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A - Proposed E-Discovery Order)(Davis, William) |
| Feb 13, 2018 | 48 | Notice (Other) (2) Docket Text: NOTICE by Lupin Atlantis Holdings SA re [37] Order,,, Terminate Motions,,, Set Deadlines/Hearings,,, Scheduling Order,, Notice of Compliance with P.R. 3-8(C) and 3-8(D) (Johnson, Michael) |
| Jan 23, 2018 | 47 | Response to Non-Motion (3) Docket Text: RESPONSE to [45] Response to Non-Motion, (Plaintiff Endo Pharmaceuticals Inc.'s REPLY to Defendant Lupin Atlantis's RESPONSE to Notice of Supplemental Authority - Re: Dkts. 41 and 45) filed by Endo Pharmaceuticals Inc. . (Davis, William) |
| Jan 22, 2018 | 46 | Notice (Other) (2) Docket Text: NOTICE by Endo Pharmaceuticals Inc. of Compliance Regarding P.R. 3-8(b) (Re: Dkt. 37) (Davis, William) |
| Jan 16, 2018 | 45 | Response to Non-Motion (3) |
| Jan 16, 2018 | 44 | Notice of Discovery Disclosure (2) Docket Text: NOTICE of Discovery Disclosure by Lupin Atlantis Holdings SA Lupin Atlantis Holdings SA's Notice of Service of Initial Disclosures (Johnson, Michael) |
| Jan 16, 2018 | 45 | Exhibit A (8) |
| Jan 16, 2018 | 45 | Exhibit B (11) |
| Jan 16, 2018 | 45 | Exhibit C (9) |
| Jan 16, 2018 | 45 | Main Document (3) Docket Text: RESPONSE to [41] Notice (Other),, Defendant's Response to Plaintiff's Notice of Supplemental Authority filed by Lupin Atlantis Holdings SA. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Johnson, Michael) |
| Jan 12, 2018 | 43 | Notice (Other) (3) Docket Text: NOTICE by Endo Pharmaceuticals Inc. of Service of Initial and Additional Disclosures (Re: Dkt. 37) (Davis, William) |
| Jan 5, 2018 | 42 | Notice of Attorney Appearance - Pro Hac Vice (2) Docket Text: NOTICE of Attorney Appearance - Pro Hac Vice by Michael Keenan Nutter on behalf of Lupin Atlantis Holdings SA. Filing fee $ 100, receipt number 0540-6611149. (Nutter, Michael) |
| Dec 28, 2017 | 41 | Notice (Other) (3) |
| Dec 28, 2017 | 41 | Exhibit A - Memorandum Order - Recent Decision by Judge Stark in the District of (8) |
| Dec 28, 2017 | 41 | Main Document (3) Docket Text: NOTICE by Endo Pharmaceuticals Inc. re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406- Plaintiff Endo Pharmaceuticals Inc.'s NOTICE OF SUPPLEMENTAL AUTHORITY (Re: Dkts. 9, 19, 22, and 27) (Attachments: # (1) Exhibit A - Memorandum Order - Recent Decision by Judge Stark in the District of Delaware in 3G Licensing, S.A. et al. v. HTC Corp. et al., No. 17-cv-00083-LPS-CJB)(Davis, William) |
| Dec 20, 2017 | 40 | Protective Order (14) Docket Text: PROTECTIVE ORDER re [39] Joint MOTION for Protective Order filed by Endo Pharmaceuticals Inc... Signed by District Judge Rodney Gilstrap on 12/20/2017. (nkl, ) |
| Dec 19, 2017 | 39 | Text of Proposed Order - Exhibit A - Proposed Protective Order (14) |
| Dec 19, 2017 | 39 | Main Document (3) Docket Text: Joint MOTION for Protective Order by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order - Exhibit A - Proposed Protective Order)(Davis, William) |
| Dec 15, 2017 | 37 | Order (6) Docket Text: DOCKET CONTROL ORDER granting [35] Joint MOTION for Entry of Docket Control Order (Re: Dkt. 25. Bench Trial set for 7/29/2019 09:00 AM before District Judge Rodney Gilstrap. Pretrial Conference set for 7/1/2019 09:00 AM before District Judge Rodney Gilstrap., Amended Pleadings due by 5/24/2018., Mediation Completion due by 5/1/2019., Markman Hearing set for 8/9/2018 01:30 PM before District Judge Rodney Gilstrap., Proposed Pretrial Order due by 6/24/2019. Signed by District Judge Rodney Gilstrap on 12/15/2017. (ch, ) |
| Dec 15, 2017 | 38 | Response to Non-Motion (5) Docket Text: RESPONSE to [34] Notice (Other), - Plaintiff Endo Pharmaceuticals Inc.'s RESPONSE to Defendant's Notice of Supplemental Authority (Re: Dkts. 9, 10, 19, and 34) filed by Endo Pharmaceuticals Inc. . (Davis, William) |
| Dec 12, 2017 | 35 | Text of Proposed Order - Exhibit A - Proposed Docket Control Order (7) |
| Dec 12, 2017 | 36 | Text of Proposed Order - Exhibit A - Proposed Discovery Order (9) |
| Dec 12, 2017 | 35 | Main Document (3) Docket Text: Joint MOTION for Entry of Docket Control Order (Re: Dkt. 25) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order - Exhibit A - Proposed Docket Control Order)(Davis, William) |
| Dec 12, 2017 | 36 | Main Document (5) Docket Text: Opposed MOTION for Entry of Discovery Order (Re: Dkt. 25) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order - Exhibit A - Proposed Discovery Order)(Davis, William) |
| Dec 7, 2017 | 34 | Notice (Other) (3) |
| Dec 7, 2017 | 34 | Exhibit A (30) |
| Dec 7, 2017 | 34 | Main Document (3) Docket Text: NOTICE by Lupin Atlantis Holdings SA re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406Defendant's Notice of Supplemental Authority (Attachments: # (1) Exhibit A)(Johnson, Michael) |
| Dec 5, 2017 | 33 | Order Referring Case to Mediator (1) Docket Text: ORDER REFERRING CASE to Mediator. Harry Lee Gil Gillam is hereby appointed as mediator. Signed by District Judge Rodney Gilstrap on 12/04/2017. (nkl, ) |
| Dec 1, 2017 | 32 | Notice of Designation of Mediator (3) Docket Text: NOTICE of Designation of Mediator, (Non-Agreement to Designate a Mediator), filed by Endo Pharmaceuticals Inc.. (Re: Dkt. 25) (Davis, William) |
| Nov 28, 2017 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Rodney Gilstrap: Scheduling Conference held on 11/28/2017. Counsel for the parties appeared and were asked if they consented to a trial before the United States Magistrate Judge. The Court then gave Markman and Jury Selection dates; deadlines for submitting Mediator names (3 days); and deadlines for submitting Agreed Scheduling and Discovery Orders (14 days). (Court Reporter Shelly Holmes, CSR-TCRR.)(jml) |
| Nov 8, 2017 | 31 | Notice (Other) (3) Docket Text: NOTICE by Lupin Atlantis Holdings SA re [29] Order on Motion for Leave to File Defendant's Notice to Maintain Documents Under Seal (Johnson, Michael) |
| Nov 6, 2017 | 28 | Order on Motion for Leave to File (2) Docket Text: ORDER granting [18] Motion for Leave to File Under Seal its Response in Opposition to Defendants Motion to Dismiss the Complaint.. Signed by District Judge Rodney Gilstrap on 11/03/2017. (nkl, ) |
| Nov 6, 2017 | 29 | Order on Motion for Leave to File (2) Docket Text: ORDER granting [21] Motion for Leave to File Under Seal Documents Attached to its Reply Memorandum in Support of its Motion to Dismiss the Complaint. Signed by District Judge Rodney Gilstrap on 11/03/2017. (nkl, ) |
| Nov 6, 2017 | 30 | Order on Motion for Leave to File (2) Docket Text: ORDER granting [26] Motion for Leave to File Under Seal its Sur-Reply in Opposition to Defendants Motion to Dismiss the Complaint. Signed by District Judge Rodney Gilstrap on 11/03/2017. (nkl, ) |
| Nov 1, 2017 | 26 | Text of Proposed Order (1) |
| Nov 1, 2017 | 26 | Main Document (3) Docket Text: Unopposed MOTION for Leave to File SUR-REPLY in Opposition to Defendant's Motion to Dismiss the Complaint Under SEAL (Re: Dkt. 9) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Oct 27, 2017 | 25 | Order (2) Docket Text: ORDER - Scheduling Conference set for 11/28/2017 01:30 PM before District Judge Rodney Gilstrap. Signed by District Judge Rodney Gilstrap on 10/27/2017. (nkl, ) |
| Oct 25, 2017 | 21 | Text of Proposed Order (1) |
| Oct 25, 2017 | 22 | Reply to Response to Motion (13) |
| Oct 25, 2017 | 22 | Exhibit 1 (3) |
| Oct 25, 2017 | 22 | Exhibit 2 will be filed under seal (1) |
| Oct 25, 2017 | 22 | Exhibit 3 will be filed under seal (1) |
| Oct 25, 2017 | 22 | Errata 4 will be filed under seal (1) |
| Oct 25, 2017 | 22 | Exhibit 5 will be filed under seal (1) |
| Oct 25, 2017 | 22 | Exhibit 6 (4) |
| Oct 25, 2017 | 22 | Exhibit 7 (2) |
| Oct 25, 2017 | 24 | Answer to Counterclaim (19) Docket Text:Plaintiff Endo Pharmaceuticals Inc.'s ANSWER to [10] Answer to Complaint, Counterclaim of Defendant Lupin Atlantis Holdings SA (Re: Dkts. 10 and 15) by Endo Pharmaceuticals Inc..(Davis, William) |
| Oct 25, 2017 | 21 | Main Document (2) Docket Text: Unopposed MOTION for Leave to File Under Seal by Lupin Atlantis Holdings SA. (Attachments: # (1) Text of Proposed Order)(Johnson, Michael) |
| Oct 25, 2017 | 22 | Main Document (13) Docket Text: REPLY to Response to Motion re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 filed by Lupin Atlantis Holdings SA. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2 will be filed under seal, # (3) Exhibit 3 will be filed under seal, # (4) Errata 4 will be filed under seal, # (5) Exhibit 5 will be filed under seal, # (6) Exhibit 6, # (7) Exhibit 7)(Johnson, Michael) |
| Oct 19, 2017 | 20 | Additional Attachments to Main Document (2) |
| Oct 19, 2017 | 20 | Exhibit - Certificate of Authorization for File Under Seal (1) |
| Oct 19, 2017 | 20 | Main Document (2) Docket Text: Additional Attachments to Main Document: [19] Sealed Response to Motion,,,,,,,,,,,,,,.. (Attachments: # (1) Exhibit - Certificate of Authorization for File Under Seal)(Davis, William) |
| Oct 18, 2017 | 18 | Text of Proposed Order (1) |
| Oct 18, 2017 | 18 | Main Document (3) Docket Text: Unopposed MOTION for Leave to File Plaintiff's RESPONSE in Opposition to Defendant's Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 UNDER SEAL (Re: Dkt. 9) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Oct 6, 2017 | 16 | Notice of Readiness for Scheduling Conference (3) Docket Text: NOTICE of Readiness for Scheduling Conference by Endo Pharmaceuticals Inc. - Plaintiff Endo Pharmaceuticals Inc.'s Notice of Readiness for Status Conference (Re: Dkts. 9 and 10) (Davis, William) |
| Oct 6, 2017 | 17 | Notice (Other) (3) Docket Text: NOTICE by Endo Pharmaceuticals Inc. - Plaintiff Endo Pharmaceuticals Inc.'s Notice of Expiration of 30-Month Stay (Davis, William) |
| Oct 3, 2017 | 14 | Order on Motion for Extension of Time to File Response/Reply (1) Docket Text: ORDER granting [12] Motion for Extension of Time to File Response/Reply re [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 Responses due by 10/18/2017. Signed by Judge Rodney Gilstrap on 10/03/2017. (nkl, ) |
| Oct 3, 2017 | 15 | Order on Motion for Extension of Time to File Response/Reply (1) Docket Text: ORDER granting [13] Motion to Extend Time to Answer or Respond to Defendant Lupin Atlantis Holdings SAs Counterclaims. Signed by Judge Rodney Gilstrap on 10/03/2017. (nkl, ) |
| Sep 27, 2017 | 12 | Text of Proposed Order (1) |
| Sep 27, 2017 | 13 | Text of Proposed Order (1) |
| Sep 27, 2017 | 12 | Main Document (3) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [9] MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Sep 27, 2017 | 13 | Main Document (3) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [10] Answer to Complaint, Counterclaim - Plaintiff Endo Pharmaceuticals Inc.'s Unopposed Motion to Extend Time to ANSWER or RESPOND to Defendant Lupin Atlantis Holdings SA's Counterclaims (Re: Dkt. 10) by Endo Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Davis, William) |
| Sep 15, 2017 | 11 | Notice of Attorney Appearance (2) Docket Text: NOTICE of Attorney Appearance by Kurt A Mathas on behalf of Lupin Atlantis Holdings SA (Mathas, Kurt) |
| Sep 13, 2017 | 8 | Corporate Disclosure Statement (3) |
| Sep 13, 2017 | 9 | Exhibit 1 (7) |
| Sep 13, 2017 | 9 | Exhibit 2 (5) |
| Sep 13, 2017 | 9 | Exhibit A-O to Ex 2 (82) |
| Sep 13, 2017 | 9 | Text of Proposed Order (2) |
| Sep 13, 2017 | 10 | Answer to Complaint (30) Docket Text:Answer, Defenses and Counterclaims of Lupin Atlantis Holdings SA ANSWER to [1] Complaint,, , COUNTERCLAIM against Endo Pharmaceuticals Inc. by Lupin Atlantis Holdings SA.(Johnson, Michael) |
| Sep 13, 2017 | 8 | Description not available (3) Docket Text: CORPORATE DISCLOSURE STATEMENT filed by Lupin Atlantis Holdings SA (Johnson, Michael) |
| Sep 13, 2017 | 9 | Main Document (29) Docket Text: MOTION to Dismiss Defendant's Memorandum in Support of its Motion to Dismiss the Complaint Under Fed. R. Civ. P. 12(b)(2) and (3) and in the Alternative to Transfer Venue Under 28 U.S.C. § 1404 or § 1406 by Lupin Atlantis Holdings SA. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit A-O to Ex 2, # (4) Text of Proposed Order)(Johnson, Michael) |
| Aug 21, 2017 | N/A | Application Granted for Extension of Time to Answer Complaint (0) Docket Text: Defendant's Unopposed First Application for Extension of Time to Answer Complaint is granted pursuant to Local Rule CV-12 for Lupin Atlantis Holdings SA to 9/13/2017. 21 Days Granted for Deadline Extension.( nkl, ) |
| Aug 21, 2017 | 7 | Unopposed Application for Extension of Time to Answer Complaint (1) Docket Text: Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Lupin Atlantis Holdings SA.( Johnson, Michael) |
| Aug 11, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Endo Pharmaceuticals Inc.. Lupin Atlantis Holdings SA served on 8/2/2017, answer due 8/23/2017. (nkl, ) |
| Jul 28, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case assigned to Judge Rodney Gilstrap. (ch, ) |
| Jul 28, 2017 | N/A | Notice of Magistrate Availability (0) Docket Text: In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form Consent to Proceed Before Magistrate Judge is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge. (ch, ) |
| Jul 28, 2017 | 1 | Complaint (40) |
| Jul 28, 2017 | 1 | Exhibit A - U.S. Patent No. 7,229,636 (11) |
| Jul 28, 2017 | 1 | Exhibit B - U.S. Patent No. 7,404,489 (14) |
| Jul 28, 2017 | 1 | Exhibit C - U.S. Patent No. 7,879,349 (13) |
| Jul 28, 2017 | 1 | Exhibit D - U.S. Patent No. 8,003,353 (13) |
| Jul 28, 2017 | 1 | Exhibit E - U.S. Patent No. 8,940,714 (13) |
| Jul 28, 2017 | 1 | Exhibit F - U.S. Patent No. 9,415,007 (13) |
| Jul 28, 2017 | 1 | Exhibit G - Label Prescribing Information (11) |
| Jul 28, 2017 | 1 | Civil Cover Sheet (1) |
| Jul 28, 2017 | 2 | Jury Demand (2) Docket Text: DEMAND for Trial by Jury by Endo Pharmaceuticals Inc.. (Davis, William) |
| Jul 28, 2017 | 3 | Corporate Disclosure Statement (2) |
| Jul 28, 2017 | 4 | Notice of Filing of Patent/Trademark Form (AO 120) (1) Docket Text: Notice of Filing of Patent/Trademark Form (AO 120). AO 120 mailed to the Director of the U.S. Patent and Trademark Office. (Davis, William) |
| Jul 28, 2017 | 5 | Summons Issued (2) Docket Text: SUMMONS Issued as to Lupin Atlantis Holdings SA. (ch, ) |
| Jul 28, 2017 | 1 | Main Document (40) Docket Text: COMPLAINT for Patent Infringement against Lupin Atlantis Holdings SA ( Filing fee $ 400 receipt number 0540-6401509.), filed by Endo Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A - U.S. Patent No. 7,229,636, # (2) Exhibit B - U.S. Patent No. 7,404,489, # (3) Exhibit C - U.S. Patent No. 7,879,349, # (4) Exhibit D - U.S. Patent No. 8,003,353, # (5) Exhibit E - U.S. Patent No. 8,940,714, # (6) Exhibit F - U.S. Patent No. 9,415,007, # (7) Exhibit G - Label Prescribing Information, # (8) Civil Cover Sheet)(Davis, William) |
| Jul 28, 2017 | 3 | Description not available (2) Docket Text: CORPORATE DISCLOSURE STATEMENT filed by Endo Pharmaceuticals Inc. identifying Corporate Parent Endo International plc for Endo Pharmaceuticals Inc.. (Davis, William) |
| Jul 28, 2017 | 1 | Complaint* (1) |
